JPRN-UMIN000019296已完成4 期
Phase 4 study of nalfurafine hydrochloride for pruritus in patients with PBC - Nalfurafine for pruritus in PBC
Teikyo University School of Medicine0 个研究点目标入组 200 人开始时间: 2015年10月9日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with a history of allergy to nalfurafine, patients with severe liver impairment (Child-Pugh grade C), patients with mild pruritus, and patients who were not indicated for nalfurafine treatment.
研究者
相似试验
已完成
不适用
Pilot Study of efficacy and safety of nalfurafine hydrochloride for jaundice associated pruritusPruritusJPRN-UMIN000033255Wakayama Medical University12
已完成
4 期
Predictive factors of efficacy of Nalfurafine hydrochloride for pruritus in patients with PBCprimary biliary cholangitisJPRN-UMIN000021681Iwate Medical University20
尚未招募
不适用
Effect of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus on sleep disorders: A study protocol for prospective interventional studyJPRN-UMIN000028161Hyogo college of medicine50
已完成
3 期
Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving HemodialysisConventional-treatment-resistant Pruritus in Patients Receiving HemodialysisNCT01513161SK Chemicals Co., Ltd.104
已完成
3 期
A clinical trial to study the effects of two drugs, naftifine and terbinafine in patients with dermatophytosis.CTRI/2009/091/000679Sun Pharmaceutical Industries Ltd.